Myriad Genetics, Inc. (NASDAQ:MYGN)

CAPS Rating: 5 out of 5

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.

Recs

0
Player Avatar Maribaza (26.67) Submitted: 11/30/2010 12:24:56 PM : Outperform Start Price: $21.68 MYGN Score: +6.33

Watchlist81 73 6685 72 29

Report this Post Reply

Featured Broker Partners


Advertisement